Calibration Methods Used in Cancer Simulation Models and Suggested Reporting Guidelines

AbstractIncreasingly, computer simulation models are used for economic and policy evaluation in cancer prevention and control. A model’s predictions of key outcomes, such as screening effectiveness, depend on the values of unobservable natural history parameters. Calibration is the process of determining the values of unobservable parameters by constraining model output to replicate observed data. Because there are many approaches for model calibration and little consensus on best practices, we surveyed the literature to catalogue the use and reporting of these methods in cancer simulation models.We conducted a MEDLINE search (1980 through 2006) for articles on cancer-screening models and supplemented search results with articles from our personal reference databases. For each article, two authors independently abstracted pre-determined items using a standard form. Data items included cancer site, model type, methods used for determination of unobservable parameter values and description of any calibration protocol. All authors reached consensus on items of disagreement. Reviews and non-cancer models were excluded. Articles describing analytical models, which estimate parameters with statistical approaches (e.g. maximum likelihood) were catalogued separately.Models that included unobservable parameters were analysed and classified by whether calibration methods were reported and if so, the methods used.The review process yielded 154 articles that met our inclusion criteria and, of these, we concluded that 131 may have used calibration methods to determine model parameters. Although the term ‘calibration’ was not always used, descriptions of calibration or ‘model fitting’ were found in 50% (n = 66) of the articles, with an additional 16% (n = 21) providing a reference to methods. Calibration target data were identified in nearly all of these articles. Other methodological details, such as the goodness-of-fit metric, were discussed in 54% (n = 47 of 87) of the articles reporting calibration methods, while few details were provided on the algorithms used to search the parameter space.Our review shows that the use of cancer simulation modelling is increasing, although thorough descriptions of calibration procedures are rare in the published literature for these models. Calibration is a key component of model development and is central to the validity and credibility of subsequent analyses and inferences drawn from model predictions. To aid peer-review and facilitate discussion of modelling methods, we propose a standardized Calibration Reporting Checklist for model documentation.

[1]  John A. Nelder,et al.  A Simplex Method for Function Minimization , 1965, Comput. J..

[2]  B. Kintz,et al.  Computational Handbook of Statistics , 1968 .

[3]  D. Nash Problems and Progress in Medical Care , 1969 .

[4]  John H. Holland,et al.  Adaptation in Natural and Artificial Systems: An Introductory Analysis with Applications to Biology, Control, and Artificial Intelligence , 1992 .

[5]  A. Miller,et al.  Optimising the age, number of tests, and test interval for cervical screening in Canada. , 1982, Journal of epidemiology and community health.

[6]  Averill M. Law,et al.  Simulation Modeling and Analysis , 1982 .

[7]  J. Habbema,et al.  Cost-effectiveness of cervical cancer screening. , 1983, Connecticut medicine.

[8]  C. D. Gelatt,et al.  Optimization by Simulated Annealing , 1983, Science.

[9]  J D Habbema,et al.  Model building on the basis of Dutch cervical cancer screening data. , 1985, Maturitas.

[10]  D. Parkin A computer simulation model for the practical planning of cervical cancer screening programmes. , 1985, British Journal of Cancer.

[11]  A. J. Valleron,et al.  A simulation model of the natural history of human breast cancer. , 1985, British Journal of Cancer.

[12]  D M Parkin,et al.  An evaluation of screening policies for cervical cancer in England and Wales using a computer simulation model. , 1986, Journal of epidemiology and community health.

[13]  D M Eddy,et al.  The frequency of cervical cancer screening. Comparison of a mathematical model with empirical data , 1987, Cancer.

[14]  J. D. F. Habbema,et al.  A simulation approach to cost-effectiveness and cost-benefit calculations of screening for the early detection of disease , 1987 .

[15]  M. Kimmel,et al.  The natural history of lung cancer in a periodically screened population. , 1987, Biometrics.

[16]  David E. Goldberg,et al.  Genetic Algorithms in Search Optimization and Machine Learning , 1988 .

[17]  D. F. Wong,et al.  Simulated Annealing for VLSI Design , 1988 .

[18]  Natural history of adenocarcinoma-large cell carcinoma of the lung: conclusions from screening programs in New York and Baltimore. , 1988, Journal of the National Cancer Institute.

[19]  E. Knox Evaluation of a proposed breast cancer screening regimen. , 1988, BMJ.

[20]  D. Eddy Screening for breast cancer. , 1989, Annals of internal medicine.

[21]  H. Adami,et al.  Natural history of cervical neoplasia: consistent results obtained by an identification technique. , 1989, British Journal of Cancer.

[22]  V Sreenivas,et al.  A simulation approach for estimating the loss of womanyears due to cervical cancer and probability of developing cervical cancer. , 1989, Neoplasma.

[23]  J. Habbema,et al.  The cost‐effectiveness of breast cancer screening , 1989, International journal of cancer.

[24]  Fred W. Glover,et al.  Tabu Search - Part I , 1989, INFORMS J. Comput..

[25]  D. Eddy Screening for cervical cancer. , 1990, Annals of internal medicine.

[26]  J D Habbema,et al.  A model for breast cancer screening , 1990, Cancer.

[27]  J. Habbema,et al.  A model‐based analysis of the hip project for breast cancer screening , 1990, International journal of cancer.

[28]  Fred Glover,et al.  Tabu Search - Part II , 1989, INFORMS J. Comput..

[29]  S. Koscielny,et al.  The natural history of breast cancer: implications for a screening strategy. , 1990, International journal of radiation oncology, biology, physics.

[30]  M A Koopmanschap,et al.  Economic aspects of cervical cancer screening. , 1990, Social science & medicine.

[31]  H. Adami,et al.  Cytologic screening for cancer of the uterine cervix in Sweden evaluated by identification and simulation. , 1990, British Journal of Cancer.

[32]  D. Singer,et al.  Quantifying the potential benefit of CA 125 screening for ovarian cancer. , 1991, Journal of clinical epidemiology.

[33]  M Kimmel,et al.  Nonparametric estimation of the size-metastasis relationship in solid cancers. , 1991, Biometrics.

[34]  P. Skrabanek The Cost-effectiveness of Breast Cancer Screening , 1991, International Journal of Technology Assessment in Health Care.

[35]  H. D. de Koning,et al.  Breast cancer screening and cost‐effectiveness; Policy alternatives, quality of life considerations and the possible impact of uncertain factors , 1991, International journal of cancer.

[36]  J. Wagner,et al.  Cost effectiveness of colorectal cancer screening in the elderly. , 1991, Annals of internal medicine.

[37]  H. Glick,et al.  Cost‐effectiveness analysis of mass screening for breast cancer in Japan , 1991, Cancer.

[38]  William H. Press,et al.  Numerical Recipes in C, 2nd Edition , 1992 .

[39]  A 50‐Year Projection of Lung Cancer Deaths among Japanese Males and Potential Impact Evaluation of Anti‐smoking Measures and Screening Using a Computerized Simulation Model , 1992, Japanese journal of cancer research : Gann.

[40]  Bruce E. Rosen,et al.  Genetic Algorithms and Very Fast Simulated Reannealing: A comparison , 1992 .

[41]  S. Mader Influence of animal age on the beta-adrenergic system in cultured rat aortic and mesenteric artery smooth muscle cells. , 1992, Journal of gerontology.

[42]  J. Beck,et al.  Effect of the Clinical Laboratory Improvement Amendments of 1988 (CLIA '88) on the Incidence of Invasive Cervical Cancer , 1992, Medical care.

[43]  K. Manton,et al.  Demographics (1950-1987) of breast cancer in birth cohorts of older women. , 1992, Journal of gerontology.

[44]  R Levine,et al.  Prevention and early detection of colorectal cancer. , 1992, American family physician.

[45]  P. Glasziou,et al.  Cost-effectiveness of mammographic screening in Australia. , 2010, Australian journal of public health.

[46]  M Kimmel,et al.  Screening for lung cancer: The Mayo lung project revisited , 1993, Cancer.

[47]  M. Cowen,et al.  A Markov model of the natural history of prostate cancer. , 1994, Journal of clinical epidemiology.

[48]  S G Pauker,et al.  Screening for prostate cancer. A decision analytic view. , 1994, JAMA.

[49]  S Mizuno,et al.  Evaluation of cancer prevention strategies by computerized simulation model: methodological issues. , 1994, Environmental health perspectives.

[50]  D. Gyrd-Hansen,et al.  A cost-effectiveness analysis of cervical cancer screening: health policy implications. , 1995, Health policy.

[51]  D. Whynes,et al.  Cost-effectiveness of screening for colorectal cancer: a simulation model. , 1995, IMA journal of mathematics applied in medicine and biology.

[52]  J. Zoetelief,et al.  MBS: a model for risk benefit analysis of breast cancer screening. , 1995, The British journal of radiology.

[53]  László Tabár,et al.  Quantitative Interpretation of Age-Specific Mortality Reductions From the Swedish Breast Cancer-Screening Trials , 1995 .

[54]  J. Habbema,et al.  A model-based prediction of the impact on reduction in mortality by a breast cancer screening programme in the city of Florence, Italy. , 1995, European journal of cancer.

[55]  H. D. de Koning,et al.  Quantitative interpretation of age-specific mortality reductions from the Swedish breast cancer-screening trials. , 1995, Journal of the National Cancer Institute.

[56]  N. Devlin,et al.  The cost-effectiveness of mammography screening: evidence from a microsimulation model for New Zealand. , 1996, Health policy.

[57]  C B Schechter,et al.  Cost-effectiveness of rescreening conventionally prepared cervical smears by PAPNET testing. , 1996, Acta cytologica.

[58]  R W Sanson-Fisher,et al.  Screening for Melanoma by Primary Health Care Physicians: A Cost—Effectiveness Analysis , 1996, Journal of medical screening.

[59]  Theodore W. Manikas,et al.  Genetic Algorithms vs. Simulated Annealing: A Comparison of Approaches for Solving the Circuit Partitioning Problem , 1996 .

[60]  N Urban,et al.  Use of a stochastic simulation model to identify an efficient protocol for ovarian cancer screening. , 1997, Controlled clinical trials.

[61]  J. Zoetelief,et al.  Assessment of lifetime gained as a result of mammographic breast cancer screening using a computer model. , 1997, The British journal of radiology.

[62]  D. Gyrd-Hansen,et al.  Analysis of screening data: colorectal cancer. , 1997, International journal of epidemiology.

[63]  J Zoetelief,et al.  Optimisation of mammographic breast cancer screening using a computer simulation model. , 1997, European journal of radiology.

[64]  I. Tsuji,et al.  Cost-effective analysis of mass screening for cervical cancer in Japan. , 1997, Journal of epidemiology.

[65]  M. Downer,et al.  An interim determination of health gain from oral cancer and precancer screening: 2. Developing a model of population screening. , 1997, Community dental health.

[66]  Jerry Banks,et al.  Handbook of simulation - principles, methodology, advances, applications, and practice , 1998, A Wiley-Interscience publication.

[67]  R. Boer,et al.  Cost Effectiveness of Shortening Screening Interval or Extending Age Range of NHS Breast Screening Programme , 1999 .

[68]  D. Whynes,et al.  Faecal occult blood screening for colorectal cancer: is it cost-effective? , 1998, Health economics.

[69]  D. Gyrd-Hansen,et al.  Colorectal cancer screening: efficiency and effectiveness. , 1998, Health economics.

[70]  Paul W. Radensky,et al.  Interactive Neural Network–Assisted Screening , 1998, Acta Cytologica.

[71]  H. D. de Koning,et al.  Radiation risk of mammography related to benefit in screening programmes: a favourable balance? , 1998, Journal of medical screening.

[72]  L. Mango,et al.  Interactive Neural Network–Assisted Screening , 1998, Acta Cytologica.

[73]  R. Baker,et al.  Use of a mathematical model to evaluate breast cancer screening policy , 1998, Health care management science.

[74]  M. Weinstein,et al.  The Costs, Clinical Benefits, and Cost-Effectiveness of Screening for Cervical Cancer in HIV-Infected Women , 1999, Annals of Internal Medicine.

[75]  P. J. van der Maas,et al.  Stage distribution at first and repeat examinations in breast cancer screening , 1999, Journal of medical screening.

[76]  D B Kopans,et al.  Breast cancer: computer simulation method for estimating optimal intervals for screening. , 1999, Radiology.

[77]  Rob Boer,et al.  The MISCAN-COLON Simulation Model for the Evaluation of Colorectal Cancer Screening , 1999, Comput. Biomed. Res..

[78]  M. Cowen,et al.  Serial prostate specific antigen screening for prostate cancer: a computer model evaluates competing strategies. , 1999, The Journal of urology.

[79]  Shinji Sato,et al.  Determining the Cost-Effectiveness of Mass Screening for Cervical Cancer Using Common Analytic Models , 1999, Acta Cytologica.

[80]  B. Bloom,et al.  Clinical and economic effects of population-based Helicobacter pylori screening to prevent gastric cancer. , 1999, Archives of internal medicine.

[81]  E. Feuer,et al.  Cancer surveillance series: interpreting trends in prostate cancer--part III: Quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality. , 1999, Journal of the National Cancer Institute.

[82]  D. Jenkins,et al.  Withdrawing low risk women from cervical screening programmes: mathematical modelling study. , 1999, BMJ.

[83]  Ruth Etzioni,et al.  Simulation modeling of outcomes and cost effectiveness. , 2000, Hematology/oncology clinics of North America.

[84]  M Arbyn,et al.  Overview of important cervical cancer screening process values in European Union (EU) countries, and tentative predictions of the corresponding effectiveness and cost-effectiveness. , 2000, European journal of cancer.

[85]  H A Guess,et al.  Comparative efficiency of prostate-specific antigen screening strategies for prostate cancer detection. , 2000, JAMA.

[86]  P. Prorok,et al.  Investigation of design and bias issues in case-control studies of cancer screening using microsimulation. , 2000, American journal of epidemiology.

[87]  J. Mitchell,et al.  A DECISION MODEL AND COST-EFFECTIVENESS ANALYSIS OF COLORECTAL CANCER SCREENING AND SURVEILLANCE GUIDELINES FOR AVERAGE-RISK ADULTS , 2000, International Journal of Technology Assessment in Health Care.

[88]  Graham A. Colditz,et al.  Cost-effectiveness of screening for colorectal cancer in the general population. , 2000, JAMA.

[89]  Robert W. Klein,et al.  Cost-utility of one-time colonoscopic screening for colorectal cancer at various ages , 2000 .

[90]  J D Habbema,et al.  Endoscopic colorectal cancer screening: a cost-saving analysis. , 2000, Journal of the National Cancer Institute.

[91]  D C McCrory,et al.  Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. , 2000, American journal of epidemiology.

[92]  C. Henschke,et al.  Modeling of long‐term screening for lung carcinoma , 2001, Cancer.

[93]  C. Earle,et al.  Potential cost-effectiveness of one-time screening for lung cancer (LC) in a high risk cohort. , 2000, Lung cancer.

[94]  J. Habbema,et al.  Impact of systematic false-negative test results on the performance of faecal occult blood screening. , 2001, European journal of cancer.

[95]  D. Pauler,et al.  Screening Based on the Risk of Cancer Calculation From Bayesian Hierarchical Changepoint and Mixture Models of Longitudinal Markers , 2001 .

[96]  T. Wright,et al.  Policy analysis of cervical cancer screening strategies in low-resource settings: clinical benefits and cost-effectiveness. , 2001, JAMA.

[97]  S K Plevritis,et al.  A mathematical algorithm that computes breast cancer sizes and doubling times detected by screening. , 2001, Mathematical biosciences.

[98]  R. Hayward,et al.  Which colon cancer screening test? A comparison of costs, effectiveness, and compliance. , 2001, The American journal of medicine.

[99]  Computer modelling of the Swedish two county trial of mammographic screening and trade offs between participation and screening interval , 2001, Journal of medical screening.

[100]  Grace Huang,et al.  Aspirin as an Adjunct to Screening for Prevention of Sporadic Colorectal Cancer: A Cost-Effectiveness Analysis , 2001, Annals of Internal Medicine.

[101]  Christopher J. Lacke,et al.  Analysis of Colorectal Cancer Screening Regimens , 2001, Health Care Management Science.

[102]  Tony Hsiu-Hsi Chen,et al.  Assessing chronic disease progression using non‐homogeneous exponential regression Markov models: an illustration using a selective breast cancer screening in Taiwan , 2002, Statistics in Medicine.

[103]  W. Lawrence,et al.  Benefits and costs of using HPV testing to screen for cervical cancer. , 2002, JAMA.

[104]  T. Wright,et al.  Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. , 2002, JAMA.

[105]  William H. Press,et al.  Numerical recipes in C , 2002 .

[106]  W. Lawrence,et al.  Costs and benefits of different strategies to screen for cervical cancer in less-developed countries. , 2002, Journal of the National Cancer Institute.

[107]  Ruth Davies,et al.  A Simulation to Evaluate Screening for Helicobacter Pylori Infection in the Prevention of Peptic Ulcers and Gastric Cancers , 2002, Health care management science.

[108]  S. Goldie Public health policy and cost-effectiveness analysis , 2003 .

[109]  N. Nagelkerke,et al.  Prevalence of family histories of breast cancer in the general population and the incidence of related seeking of health care , 2003, Journal of medical genetics.

[110]  S. Goldie Chapter 15: Public health policy and cost-effectiveness analysis. , 2003, Journal of the National Cancer Institute. Monographs.

[111]  J. Faivre,et al.  A simulation model for evaluating the medical and economic outcomes of screening strategies for colorectal cancer , 2003, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[112]  E. Halpern,et al.  Estimates of Breast Cancer Growth Rate and Sojourn Time from Screening Database Information , 2003 .

[113]  Harry J de Koning,et al.  Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer. , 2003, Journal of the National Cancer Institute.

[114]  P. Roderick,et al.  The cost-effectiveness of screening for Helicobacter pylori to reduce mortality and morbidity from gastric cancer and peptic ulcer disease: a discrete-event simulation model. , 2003, Health Technology Assessment.

[115]  P. Walsh,et al.  Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. , 2003, The Journal of urology.

[116]  Analysis of benefit:risk ratio and mortality reduction for the UK Breast Screening Programme. , 2003, The British journal of radiology.

[117]  Cost-effectiveness of population screening for Helicobacter pylori in preventing gastric cancer and peptic ulcer disease, using simulation. , 2003, Journal of medical screening.

[118]  H. D. de Koning,et al.  MISCAN: estimating lead‐time and over‐detection by simulation , 2003, BJU international.

[119]  M. Weinstein,et al.  A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV‐16/18 vaccine , 2003, International journal of cancer.

[120]  Daniel B. Kopans,et al.  Estimates of the Sizes at Which Breast Cancers Become Detectable on Mammographic and Clinical Grounds , 2003 .

[121]  A. Fendrick,et al.  Potential effect of cyclooxygenase-2-specific inhibitors on the prevention of colorectal cancer: a cost-effectiveness analysis. , 2003, The American journal of medicine.

[122]  L. Tabár,et al.  Bayesian evaluation of breast cancer screening using data from two studies , 2003, Statistics in medicine.

[123]  K. Kerlikowske,et al.  Risk of cervical cancer associated with extending the interval between cervical-cancer screenings. , 2003, The New England journal of medicine.

[124]  John Eng,et al.  Lung cancer screening with helical computed tomography in older adult smokers: a decision and cost-effectiveness analysis. , 2003, JAMA.

[125]  Milton C Weinstein,et al.  Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies. , 2003, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[126]  Frank Castro,et al.  A computer model for the study of breast cancer , 2003, Comput. Biol. Medicine.

[127]  Louis P Garrison The ISPOR Good Practice Modeling Principles--a sensible approach: be transparent, be reasonable. , 2003, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[128]  W. Lawrence,et al.  The balance of harms, benefits, and costs of screening for cervical cancer in older women: the case for continued screening. , 2004, Archives of internal medicine.

[129]  Milton C Weinstein,et al.  Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine. , 2004, Journal of the National Cancer Institute.

[130]  T. Wright,et al.  Cost-Effectiveness of Human Papillomavirus DNA Testing for Cervical Cancer Screening in Women Aged 30 Years or More , 2004, Obstetrics and gynecology.

[131]  Peter Muennig,et al.  Benefits and costs of interventions to improve breast cancer outcomes in African American women. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[132]  E. Feuer,et al.  The use of modeling to understand the impact of screening on US mortality: examples from mammography and PSA testing , 2004, Statistical methods in medical research.

[133]  H. D. de Koning,et al.  Trends in the usage of adjuvant systemic therapy for breast cancer in the Netherlands and its effect on mortality , 2004, British Journal of Cancer.

[134]  S. Duffy,et al.  Progression Rates of Colorectal Cancer by Dukes' Stage in a High‐Risk Group: Analysis of Selective Colorectal Cancer Screening , 2004, Cancer journal.

[135]  Evaluation of cancer prevention strategies by computerized simulation model: an approach to lung cancer , 1991, Cancer Causes & Control.

[136]  J. Faivre,et al.  Cost-effectiveness analysis of fecal occult blood screening for colorectal cancer , 2004, International Journal of Technology Assessment in Health Care.

[137]  Z. Philips,et al.  An evaluation of liquid-based cytology and human papillomavirus testing within the UK cervical cancer screening programme , 2004, British Journal of Cancer.

[138]  H. Adami,et al.  Optimization of cervical cancer screening , 1992, Cancer Causes & Control.

[139]  G. Leung,et al.  Cost-effectiveness of organized versus opportunistic cervical cytology screening in Hong Kong. , 2004, Journal of public health.

[140]  Simulation of Breast Cancer Screening: Quality Assessment of Two Protocols , 2004, Journal for healthcare quality : official publication of the National Association for Healthcare Quality.

[141]  A. Fendrick,et al.  Fecal DNA testing compared with conventional colorectal cancer screening methods: a decision analysis. , 2004, Gastroenterology.

[142]  Barbara L. Smith,et al.  Mammographic screening: Patterns of use and estimated impact on breast carcinoma survival , 2004, Cancer.

[143]  Yen Lin Chia,et al.  Simulation-based parameter estimation for complex models: a breast cancer natural history modelling illustration , 2004, Statistical methods in medical research.

[144]  D. Hunter,et al.  Simulation modeling of change to breast cancer detection age eligibility recommendations in Ontario, 2002-2021. , 2004, Cancer detection and prevention.

[145]  M. Zelen,et al.  Robust modeling in screening studies: estimation of sensitivity and preclinical sojourn time distribution. , 2005, Biostatistics.

[146]  J. Berkhof,et al.  Natural history and screening model for high‐risk human papillomavirus infection, neoplasia and cervical cancer in the Netherlands , 2005, International journal of cancer.

[147]  Sue J Goldie,et al.  Cost-effectiveness of cervical-cancer screening in five developing countries. , 2005, The New England journal of medicine.

[148]  A. Miller,et al.  Estimation of age‐specific sensitivity and sojourn time in breast cancer screening studies , 2005, Statistics in medicine.

[149]  M. Zelen,et al.  Inferring the natural time history of breast cancer: Implications for tumor growth rate and early detection , 2005, Breast Cancer Research and Treatment.

[150]  Frank Castro,et al.  The relation of breast cancer staging to screening protocol compliance: a computer simulation study , 2005, Comput. Biol. Medicine.

[151]  H. Brenner,et al.  A Simulation Model for Colorectal Cancer Screening: Potential of Stool Tests with Various Performance Characteristics Compared with Screening Colonoscopy , 2005, Cancer Epidemiology Biomarkers & Prevention.

[152]  D. Berry,et al.  Effect of screening and adjuvant therapy on mortality from breast cancer , 2005 .

[153]  K. S. Ross,et al.  Estimation of treatment benefits when PSA screening for prostate cancer is discontinued at different ages. , 2005, Urology.

[154]  Yu Shen,et al.  Nonparametric Estimation of Asymptomatic Duration from a Randomized Prospective Cancer Screening Trial , 2005, Biometrics.

[155]  A Tsodikov,et al.  A population model of prostate cancer incidence , 2006, Statistics in medicine.

[156]  T. Chen,et al.  Evolution of multiple disease screening in Keelung: a model for community involvement in health interventions? , 2006, Journal of medical screening.

[157]  D. Dearnaley,et al.  A model of the natural history of screen-detected prostate cancer, and the effect of radical treatment on overall survival , 2006, British Journal of Cancer.

[158]  Jennifer Cullen,et al.  The SPECTRUM population model of the impact of screening and treatment on U.S. breast cancer trends from 1975 to 2000: principles and practice of the model methods. , 2006, Journal of the National Cancer Institute. Monographs.

[159]  N. Nagelkerke,et al.  Breast Cancer Screening, Outside the Population-Screening Program, of Women from Breast Cancer Families without Proven BRCA1/BRCA2 Mutations: a Simulation Study , 2006, Cancer Epidemiology Biomarkers & Prevention.

[160]  C. Earle,et al.  Computed tomography screening for lung cancer in Hodgkin's lymphoma survivors: decision analysis and cost-effectiveness analysis. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[161]  A. Berchuck,et al.  Genomic tests for ovarian cancer detection and management. , 2006, Evidence report/technology assessment.

[162]  Vipat Kuruchittham,et al.  The Wisconsin Breast Cancer Epidemiology Simulation Model. , 2006, Journal of the National Cancer Institute. Monographs.

[163]  P. Glynn,et al.  A stochastic simulation model of U.S. breast cancer mortality trends from 1975 to 2000. , 2006, Journal of the National Cancer Institute. Monographs.

[164]  H. D. de Koning,et al.  Gleason score, age and screening: Modeling dedifferentiation in prostate cancer , 2006, International journal of cancer.

[165]  K. Kerlikowske,et al.  Cost-effectiveness of Extending Cervical Cancer Screening Intervals Among Women With Prior Normal Pap Tests , 2006, Obstetrics and gynecology.

[166]  T. Chen,et al.  Colorectal cancer screening with faecal occult blood test within a multiple disease screening programme: an experience from Keelung, Taiwan. , 2006, Journal of medical screening.

[167]  M. Zelen,et al.  A stochastic model for predicting the mortality of breast cancer. , 2006, Journal of the National Cancer Institute. Monographs.

[168]  Harry J de Koning,et al.  The MISCAN-Fadia continuous tumor growth model for breast cancer. , 2006, Journal of the National Cancer Institute. Monographs.

[169]  H. D. de Koning,et al.  Seventy‐five years is an appropriate upper age limit for population‐based mammography screening , 2006, International journal of cancer.

[170]  J. Berkhof,et al.  Evaluation of cervical screening strategies with adjunct high‐risk human papillomavirus testing for women with borderline or mild dyskaryosis , 2006, International journal of cancer.

[171]  Maureen A Smith,et al.  Retrospective cost-effectiveness analysis of screening mammography. , 2006, Journal of the National Cancer Institute.

[172]  Eric J Feuer,et al.  A comparative review of CISNET breast models used to analyze U.S. breast cancer incidence and mortality trends. , 2006, Journal of the National Cancer Institute. Monographs.

[173]  A. Yakovlev,et al.  The University of Rochester model of breast cancer detection and survival. , 2006, Journal of the National Cancer Institute. Monographs.

[174]  M. Pitt,et al.  Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling. , 2006, Health technology assessment.

[175]  Natasha K. Stout,et al.  Chapter 7: The Wisconsin Breast Cancer Epidemiology Simulation Model , 2006 .

[176]  Bruce L Daniel,et al.  Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging. , 2006, JAMA.

[177]  T. Chen,et al.  Efficacy and cost-effectiveness of nationwide cervical cancer screening in Taiwan. , 2006, Journal of medical screening.

[178]  Jeremy D Goldhaber-Fiebert,et al.  Chapter 18: Public health policy for cervical cancer prevention: the role of decision science, economic evaluation, and mathematical modeling. , 2006, Vaccine.

[179]  Lurdes Y. T. Inoue,et al.  Modeling the impact of treatment and screening on U.S. breast cancer mortality: a Bayesian approach. , 2006, Journal of the National Cancer Institute. Monographs.

[180]  J. Halliday,et al.  Using record linkage and manual follow-up to evaluate the Victorian maternal serum screening quadruple test for Down's syndrome, trisomy 18 and neural tube defects , 2006, Journal of medical screening.

[181]  G. Gazelle,et al.  Use of modeling to evaluate the cost-effectiveness of cancer screening programs. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[182]  Karen M Kuntz,et al.  Multiparameter calibration of a natural history model of cervical cancer. , 2007, American journal of epidemiology.

[183]  Sylvia K Plevritis,et al.  A natural history model of stage progression applied to breast cancer , 2007, Statistics in medicine.

[184]  Jeremy D Goldhaber-Fiebert,et al.  Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccination , 2007, Population health metrics.

[185]  M. Ezzati,et al.  Development of an Empirically Calibrated Model of Gastric Cancer in Two High-Risk Countries , 2008, Cancer Epidemiology Biomarkers & Prevention.

[186]  G Scott Gazelle,et al.  Calibration of disease simulation model using an engineering approach. , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[187]  Milton C. Weinstein,et al.  Recent Developments in Decision-Analytic Modelling for Economic Evaluation , 2012, PharmacoEconomics.

[188]  Richard G. White,et al.  Calibrating Models in Economic Evaluation , 2012, PharmacoEconomics.